Estimating rural households’ willingness to pay for health insurance Ali AsgaryKen WillisMojtaba Rafeian Original Paper Pages: 209 - 215
Measuring and comparing the (in)efficiency of German and Swiss hospitals Lukas SteinmannGunnar DittrichPeter Zweifel Original Papers Pages: 216 - 226
Costs and consequences of botulinum toxin type A use Francis J. RuizJulian F. GuestGötz Dreiss Original Papers Pages: 227 - 235
The cost structure of lung tuberculosis in Germany Roland DielBernhard RappenhönerTom Schaberg Original Paper Pages: 243 - 251
Financing of health care services in Hungary Imre BonczJúlia NagyLászló Kőrösi Original Papers Pages: 252 - 258
Health care provider payment mechanisms in the new EU members of Central Europe and the Baltic states Agota SzendeZsolt Mogyorosy Commentary Pages: 259 - 262
Reimbursement of glitazones in treatment of type 2 diabetes patients in Denmark in the context of a voluntary system for submitting pharmacoeconomic studies Hindrik VondelingPeter Bindslev Iversen Original Paper Pages: 263 - 269
Costs of treatment of colorectal cancer in different settings in Germany Klaus HiekeUlrich R. KleebergAxel Grothey Original Papers Pages: 270 - 273
Out-patient drug policy by clinical assessment rather than financial constraints? Marja H. PronkGouke J. Bonsel OriginalPaper Pages: 274 - 277
A pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes in Spain Juan Antonio Gómez-GeriqueRoman CascianoJavier Rejas Original Papers Pages: 278 - 284
